Bioptamers
Ricardo di Lazzaro Filho is an experienced executive in the field of genomics and biotechnology, currently serving as Head of Consumer Genomics and Medical Director of Genomics and Bioinformatics at Dasa since February 2019. As CEO and co-founder of Genera, the leading consumer genomics laboratory in Latin America, Ricardo has overseen significant growth and product development. In addition to these roles, involvement as an advisor and investor spans multiple companies, including Liti, NAIAD Drug Design, Mirscience Therapeutics, MaChiron, VRMonkey, Sling Hub, Nulinga, and Bioptamers. Ricardo's educational background includes a Doctor of Philosophy in Genetics and Evolutionary Biology, a Master of Science in Genetic Counseling and Human Genomics, a Doctor of Medicine, and a Doctor of Pharmacy, all obtained from the Universidade de São Paulo.
This person is not in any teams
This person is not in any offices
Bioptamers
Bioptamers works on the development and marketing of a new class of personalized therapies. Key elements of their strategy are the collaboration with universities, private companies, and hospitals to accelerate the translation of their expertise into improvements in clinical outcomes for cancer patients.